Recursion Pharmaceuticals
RXRX
#4123
Rank
A$3.35 B
Marketcap
$8.34
Share price
3.83%
Change (1 day)
-38.07%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2024 (TTM): -A$0.72 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are A$58.48 Million. a decrease over its 2023 earnings that were of -A$0.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.74 Billion39.51%
2023 -A$0.53 Billion38.68%
2022 -A$0.38 Billion30.46%
2021 -A$0.29 Billion114.28%
2020 -A$0.14 Billion